BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,987,772 | +6.6% | 450,124 | +28.7% | 0.02% | +9.1% |
| Q2 2023 | $15,936,806 | +34.6% | 349,802 | +19.8% | 0.02% | +29.4% |
| Q1 2023 | $11,840,821 | -21.3% | 291,934 | -1.1% | 0.02% | -26.1% |
| Q4 2022 | $15,045,932 | +23.1% | 295,187 | +30.1% | 0.02% | +15.0% |
| Q3 2022 | $12,219,000 | -88.2% | 226,884 | -85.9% | 0.02% | -87.7% |
| Q2 2022 | $103,621,000 | -12.9% | 1,613,273 | +5.2% | 0.16% | 0.0% |
| Q1 2022 | $118,959,000 | -3.6% | 1,534,182 | +6.8% | 0.16% | -0.6% |
| Q4 2021 | $123,362,000 | +11.9% | 1,437,102 | +4.8% | 0.16% | +0.6% |
| Q3 2021 | $110,247,000 | +5.4% | 1,370,713 | +5.5% | 0.16% | +3.2% |
| Q2 2021 | $104,636,000 | -0.5% | 1,299,752 | +4.2% | 0.16% | -9.2% |
| Q1 2021 | $105,171,000 | +10.9% | 1,247,003 | +5.5% | 0.17% | +2.4% |
| Q4 2020 | $94,828,000 | +5.7% | 1,181,805 | +5.9% | 0.17% | -8.6% |
| Q3 2020 | $89,712,000 | -4.4% | 1,115,534 | +2.4% | 0.18% | -14.4% |
| Q2 2020 | $93,835,000 | +9.8% | 1,089,824 | +3.9% | 0.22% | -8.5% |
| Q1 2020 | $85,434,000 | -6.3% | 1,049,101 | -3.0% | 0.24% | +24.2% |
| Q4 2019 | $91,214,000 | +60.4% | 1,082,066 | +66.9% | 0.19% | +31.0% |
| Q3 2019 | $56,862,000 | -5.2% | 648,373 | -11.1% | 0.14% | -6.5% |
| Q2 2019 | $59,952,000 | +2.1% | 729,211 | +1.3% | 0.16% | -6.6% |
| Q1 2019 | $58,728,000 | +18.2% | 719,598 | -3.9% | 0.17% | +3.1% |
| Q4 2018 | $49,682,000 | -3.1% | 748,647 | +13.0% | 0.16% | +9.5% |
| Q3 2018 | $51,284,000 | +5.0% | 662,537 | +0.7% | 0.15% | -2.0% |
| Q2 2018 | $48,823,000 | +11.7% | 657,843 | -1.5% | 0.15% | +8.7% |
| Q1 2018 | $43,691,000 | +0.4% | 667,681 | -0.3% | 0.14% | 0.0% |
| Q4 2017 | $43,530,000 | +5.3% | 669,814 | +2.7% | 0.14% | -3.5% |
| Q3 2017 | $41,338,000 | -0.1% | 652,369 | -4.1% | 0.14% | -6.5% |
| Q2 2017 | $41,372,000 | +21.8% | 680,185 | +4.7% | 0.15% | +16.8% |
| Q1 2017 | $33,957,000 | +5.9% | 649,708 | -9.7% | 0.13% | -3.7% |
| Q4 2016 | $32,051,000 | -0.5% | 719,891 | +6.9% | 0.14% | -6.2% |
| Q3 2016 | $32,199,000 | +4.0% | 673,570 | -1.6% | 0.14% | +1.4% |
| Q2 2016 | $30,953,000 | +39.3% | 684,497 | +26.5% | 0.14% | +21.2% |
| Q1 2016 | $22,223,000 | +32.4% | 540,947 | +23.1% | 0.12% | +35.6% |
| Q4 2015 | $16,779,000 | +57.1% | 439,323 | +35.2% | 0.09% | +45.0% |
| Q3 2015 | $10,683,000 | -87.0% | 324,955 | -72.4% | 0.06% | -72.2% |
| Q2 2015 | $82,280,000 | +150.1% | 1,178,236 | +145.6% | 0.22% | +20.0% |
| Q1 2015 | $32,897,000 | +3.0% | 479,699 | +10.1% | 0.18% | +1.7% |
| Q4 2014 | $31,927,000 | +55.0% | 435,629 | +51.8% | 0.18% | -2.2% |
| Q3 2014 | $20,599,000 | +3.9% | 287,028 | +4.7% | 0.18% | +1.7% |
| Q2 2014 | $19,828,000 | +9.1% | 274,244 | +11.1% | 0.18% | +2.3% |
| Q1 2014 | $18,166,000 | – | 246,887 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |